GC-RISE PHARMACEUTICAL

GC-Rise Pharmaceutical Co., Ltd. is a solely-foreign-owned enterprise invested by INVENTAGES, a famous European investment group engaged in healthcare industry. Taking “Devoted to human healthcare and a better life” as our mission, the company makes full use of the business networks of our strategic cooperation partner in America, Europe and Japan, their affluent experiences in clinical development, clinical trials and registration in China, and their abundant strength in commercial distribution, hospital sale, marketing, so as to provide novel, safe, and highly efficient medical products and treatment ideas for Chinese patients.
GC-RISE PHARMACEUTICAL
Industry:
Enterprise Health Care Pharmaceutical
Founded:
2008-01-01
Address:
Chaoyang, Liaoning, China
Country:
China
Website Url:
http://www.gc-rise.com
Total Employee:
1+
Status:
Closed
Contact:
86 10 6581 1616
Total Funding:
19.74 M USD
Technology used in webpage:
Nginx Baidu Analytics LeaseWeb
Similar Organizations
Immutep
Immutep is a biopharmaceutical company developing immunotherapeutics in oncology.
Obsidian Therapeutics
Obsidian Therapeutics is a developer of a next-generation cell and gene therapies created to extend adoptive immunotherapy.
Scilex Pharmaceuticals
Scilex Pharmaceuticals is an emerging pharmaceutical company focused on acquiring and commercializing late-stage prescription products.
Current Employees Featured
Founder
Investors List
OrbiMed
OrbiMed investment in Series B - GC-Rise Pharmaceutical
Inventages Venture Capital Investment Inc.
Inventages Venture Capital Investment Inc. investment in Series A - GC-Rise Pharmaceutical
Official Site Inspections
http://www.gc-rise.com
- Host name: 38.38.81.182
- IP address: 38.38.81.182
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago

More informations about "GC-Rise Pharmaceutical"
GC-Rise 2025 Company Profile: Valuation, Funding & Investors
Information on valuation, funding, cap tables, investors, and executives for GC-Rise. Use the PitchBook Platform to explore the full profile.See details»
GC-Rise Pharmaceutical - VentureRadar
"GC-Rise Pharmaceutical Co., Ltd. is a pharmaceutical company that brings Western natural medicine with proven clinical benefits to China. The company received approval for Remifemin …See details»
GC-Rise Pharmaceutical Co., Ltd. - Drug pipelines, Patents, Clinical ...
About GC-Rise Pharmaceutical Co. Ltd GC-Rise Pharmaceutical Co. Ltd, established in 2008, is a wholly-owned foreign enterprise invested by INVENTAGES, a major European healthcare …See details»
GC-Rise Pharmaceutical - Products, Competitors, Financials, …
Sep 2, 2014 About GC-Rise Pharmaceutical GC-Rise Pharmaceutical is a pharmaceutical company that aims to bring Western natural medicine with proven clinical benefits to China. …See details»
gc-rise – Funding, Valuation, Investors, News
GC-Rise’s mission is to improve women and children’s healthcare in China through innovation. The company has 2 lead drug products in the Chinese market; Remifemin as an alternative to …See details»
GC-Rise Pharmaceutical Co Ltd - Company Profile and News
Company profile page for GC-Rise Pharmaceutical Co Ltd including stock price, company news, executives, board members, and contact informationSee details»
Gc-rise Pharmaceutical Co. Ltd. - BioCentury Company Profiles
May 17, 2010 Historical deals and financings can be found by searching the organization's name in the BCIQ Deals and Financing Modules.See details»
GC-Rise Pharmaceutical - Overview, News & Similar companies
About GC-Rise Pharmaceutical Ningguang Network Co., Ltd. in Neijiang City specializes in providing innovative networking solutions. The company offers a range of services that cater to …See details»
GCR Pharmaceutical (BeiJing) Co., Ltd. (北京德斯瑞驰医药科技有限 …
May 7, 2025 About GC-Rise Pharmaceutical Co. Ltd GC-Rise Pharmaceutical Co. Ltd, established in 2008, is a wholly-owned foreign enterprise invested by INVENTAGES, a major …See details»
GC-rise | LinkedIn
Employees at GC-rise Howard Zhanghao Director Strategy Development & Oncology Business Department Jinhui Yang Business Development Manager at GC-Rise 琼吴 gc-rise accountantSee details»
CEO & President @ GC-Rise Pharmaceutical - Crunchbase
Prior to joining GC-Rise, Mr. Zhang was the Chief Operating Officer of RHEI pharmaceutical company which was young US base company. Before that time, he was BMS Anti-infective, …See details»
GC-Rise Pharmaceutical - Funding, Financials, Valuation & Investors
GC-Rise Pharmaceutical is funded by 2 investors. OrbiMed and Inventages Venture Capital Investment Inc. are the most recent investors. Which investors participated in the most funding …See details»
GC-Rise Pharmaceutical - Contacts, Employees, Board
GC-Rise Pharmaceutical Co., Ltd. is a solely-foreign-owned enterprise invested by INVENTAGES,See details»
Wren Zhang - CEO & President - GC-Rise Pharmaceutical Co.,Ltd.
Owner, GC-Rise Pharmaceutical Co.,Ltd. · 工作经历: GC-Rise Pharmaceutical Co.,Ltd. · 教育经历: BeiJing City University · 地点: 北京市 · 3 位领英好友。在领英 (一个拥有 10 亿会员的职业社 …See details»
GC-Rise grabs $15 mln from OrbiMed - Venture Capital Journal
Sep 2, 2014 GC-Rise said Monday that it has secured $15 million in Series B round financing. The investor was OrbiMed. In addition to the funding, Dr. Jonathan Wang, co-founder and …See details»
GC-Rise Pharmaceutical - Crunchbase
GC-Rise Pharmaceutical Co., Ltd. is a solely-foreign-owned enterprise invested by INVENTAGES,See details»
gc-rise: Revenue, Worth, Valuation & Competitors 2024
Gc-rise has an estimated revenue of -, and 20 employees. Alternatives of gc-rise are G. D. BARRI and ASSOCIATES, Connecticut GI and MetalX.See details»
Women Health Expert GC-Rise Wins Deloitte's 50 Top-performing …
Oct 8, 2012 Beijing-headquartered GC-Rise, which focuses on women's health in China, was the only pharmaceutical company to receive the award, with most others engaged in software and …See details»
捷斯瑞 | 项目信息-36氪
捷斯瑞健康科学是一家由行业著名投资集团INVENTAGES、亿方投资及奥博资本在华投资的外商独资企业。公司秉承“创新引领人类健康,创造美好生活”的使命,专注于妇科、产科与儿科三大 …See details»
Public Safety Canada's 2025 to 2026 Departmental Plan
In 2025 to 2026, Public Safety Canada will continue to advance its agenda on promoting equity, diversity, inclusion and accessibility in the organization. It will aim to increase collective …See details»